No Patient Left Behind Program
Improving quality of care when it's needed most
A comprehensive product training solution offered virtually by our ActiGraft experts designed to fit your schedule. The ActiGraft® Virtual Training program teaches everything you need to know to begin offering ActiGraft® inside your health care setting.
Our dedicated, knowledgeable team will be at your side every step of the way. We collaborate with your team on a virtual level with no onsite consultation required! This program is designed to help wound care professionals provide the best treatment to patients while improving quality of care. patient’s blood into an autologous clot that promotes the body’s natural wound healing processes.
RedDress® is committed to improving the health and lives of patients around the world by offering AcitGraft Virtual Training to treat chronic and acute wounds. We strongly believe that every patient deserves access to the best treatment possible.
- Step 1. Register using the form below
- Step 2. 15-30 min virtual product and procedure training will be scheduled
- Step 3. Patient selection & inventory coordination
- Step 4. Live remote ActiGraft® procedure and support
“As doctors, our schedules are hectic. The RedDress No Patient Left Behind program allowed us to schedule a virtual session so that my team and I were able to learn how to use and implement ActiGraft. The flexibility of the program – training that can be conducted virtually anywhere, anytime – is a huge benefit. ActiGraft is very easy to use and I would recommend it to any medical professional looking to improve quality of care.”
“I was very impressed with RedDress’ No Patient Left Behind Virtual Training. The program taught my team and me how to use and implement ActiGraft, without having to carve a significant amount of time from our schedules. The process was simple and easy, and RedDress’ team of experts was there to help every step of the way. I would recommend this training to any physician looking to adopt ActiGraft into their practice.”
Evidence from clinical trials confirm strong efficacy results demonstrating high effectiveness of healing hard-to-treat wounds and ulcers with the use of an Autologous blood clot.
71% of chronic wounds completely healed using ActiGraft versus 22% using the standard of care.